Michael Friedman - Intuitive Surgical Director
ISRG Stock | USD 366.34 6.29 1.69% |
Director
Dr. Michael A. Friedman, M.D. is Independent Director of the Company. Dr. Friedman currently serves as the Emeritus Cancer Center Director at City of Hope, a leading cancer research, treatment and education institution. Dr. Friedman was the President and Chief Executive Officer of City of Hope from May 2003 to December 2013 and holder of the Irell Manella Cancer Center Directors Distinguished Chair. Before leading City of Hope, from September 2001 until April 2003, Dr. Friedman held the position of Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a Senior Vice President of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr. Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1999. Dr. Friedman has also served on the Board of Directors of MannKind Corporation since December 2003, Celgene Corporation since February 2011, and Smith Nephew plc since April 2013 since 2015.
Age | 73 |
Tenure | 9 years |
Professional Marks | Ph.D |
Address | 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 |
Phone | 408 523 2100 |
Web | https://www.intuitive.com |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0777 % which means that it generated a profit of $0.0777 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1483 %, meaning that it created $0.1483 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The Intuitive Surgical's current Return On Tangible Assets is estimated to increase to 0.13. The Intuitive Surgical's current Return On Capital Employed is estimated to increase to 0.13. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 8.3 B, while Other Assets are projected to decrease to roughly 1.1 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
Elisha Finney | Mettler Toledo International | 59 | |
Arthur Bowman | Illumina | 69 | |
Elaine Ullian | Thermo Fisher Scientific | 70 | |
Wah Chu | Mettler Toledo International | 62 | |
John Thompson | Illumina | 68 | |
Edward Conard | Waters | 63 | |
Martin Harris | Thermo Fisher Scientific | 61 | |
Robert Bertolini | Charles River Laboratories | 59 | |
Frances Arnold | Illumina | 61 | |
Hans Maerki | Mettler Toledo International | 71 | |
WahHui Chu | Mettler Toledo International | 69 | |
Stanley Meresman | Guardant Health | 71 | |
Mala Anand | Agilent Technologies | 53 | |
James Mullen | Thermo Fisher Scientific | 62 | |
JeanPaul Mangeolle | Charles River Laboratories | 57 | |
Francis deSouza | Illumina | 53 | |
Dipchand Nishar | Guardant Health | N/A | |
Aaref Hilaly | Guardant Health | 46 | |
Bahija Jallal | Guardant Health | 56 | |
Joshua Bekenstein | Waters | 56 | |
Constance Harvey | Mettler Toledo International | 56 |
Management Performance
Return On Equity | 0.15 | ||||
Return On Asset | 0.0777 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Rosa, Chief Commercial Officer and Executive VP | ||
Mark Brosius, Senior Officer | ||
Mark Rubash, Independent Director | ||
Michael Friedman, Director | ||
Gary Loeb, G Officer | ||
Robert DeSantis, Executive Officer | ||
Philip Kim, Head Relations | ||
Keith Leonard, Director | ||
Ian Purdy, Senior Assurance | ||
Julian Nikolchev, Sr Strategy | ||
Gillian EdD, Senior ServicesWorldwide | ||
Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
Gary JD, General VP | ||
Amal Johnson, Independent Director | ||
Craig Barratt, Independent Director | ||
Eric Halvorson, Independent Director | ||
Lonnie Smith, Chairman and Executive Officer | ||
Jami Nachtsheim, Independent Director | ||
Gary Guthart, CEO and President and Director | ||
Marc Bland, GM VP | ||
Alan Levy, Independent Director | ||
Don Kania, Director | ||
Myriam Curet, Senior Vice President Chief Medical Officer | ||
Mark Meltzer, Chief Compliance Officer, Sr. VP and General Counsel | ||
Colin Morales, Senior Vice President - Manufacturing and Service Operations | ||
MD FACS, Executive Officer | ||
Glenn Vavoso, Senior APAC | ||
Salvatore Brogna, Executive VP of Product Operations | ||
Brian Miller, Executive Officer | ||
George Stalk, Independent Director | ||
Amy Ladd, Director | ||
Henry Charlton, Senior Officer | ||
Fredrik Widman, Principal VP | ||
Marshall Mohr, Executive Services | ||
Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.15 | ||||
Return On Asset | 0.0777 | ||||
Profit Margin | 0.25 % | ||||
Operating Margin | 0.23 % | ||||
Current Valuation | 126.24 B | ||||
Shares Outstanding | 354.45 M | ||||
Shares Owned By Insiders | 0.53 % | ||||
Shares Owned By Institutions | 88.26 % | ||||
Number Of Shares Shorted | 3.41 M | ||||
Price To Earning | 69.96 X |
Intuitive Surgical Investors Sentiment
The influence of Intuitive Surgical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Intuitive. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Intuitive Surgical's public news can be used to forecast risks associated with an investment in Intuitive. The trend in average sentiment can be used to explain how an investor holding Intuitive can time the market purely based on public headlines and social activities around Intuitive Surgical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Intuitive Surgical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intuitive Surgical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Intuitive Surgical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Intuitive Surgical.
Intuitive Surgical Implied Volatility | 35.83 |
Intuitive Surgical's implied volatility exposes the market's sentiment of Intuitive Surgical stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Intuitive Surgical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Intuitive Surgical stock will not fluctuate a lot when Intuitive Surgical's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intuitive Surgical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intuitive Surgical's short interest history, or implied volatility extrapolated from Intuitive Surgical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Intuitive Stock analysis
When running Intuitive Surgical's price analysis, check to measure Intuitive Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intuitive Surgical is operating at the current time. Most of Intuitive Surgical's value examination focuses on studying past and present price action to predict the probability of Intuitive Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intuitive Surgical's price. Additionally, you may evaluate how the addition of Intuitive Surgical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Intuitive Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.857 | Earnings Share 5.03 | Revenue Per Share 20.285 | Quarterly Revenue Growth 0.165 | Return On Assets 0.0777 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.